Economic evaluations in the Canadian Common Drug Review
Laupacis A. Pharmacoeconomics. 2006; 24(11):1157-62.
Publications
Cardiac valvulopathy associated with pergolide use
Zadikoff C, Rochon P, Lang A. Can J Neurol Sci. 2006; 33(1):27-33.
Impact of adverse events on prescribing warfarin in patients with atrial fibrillation: matched pair analysis
Choudhry NK, Anderson GM, Laupacis A, Ross-Degnan D, Normand SL, Soumerai SB. BMJ. 2006; 332(7534):141-5. Epub 2006 Jan 10.
The impact of the Canadian Hypertension Education Program on antihypertensive prescribing trends
Campbell NR, Tu K, Brant R, Duong-Hua M, McAlister FA; Canadian Hypertension Education Program Outcomes Research Task Force. Hypertension. 2006; 47(1):22-8. Epub 2005 Dec 12.
Antidepressants, warfarin and the risk of hemorrhage
Kurdyak PA, Juurlink DN, Kopp A, Herrmann N, Mamdani MM. J Clin Psychopharmacol. 2005; 25(6):561-4.
The safety of levofloxacin in elderly patients on warfarin
Stroud LF, Mamdani MM, Kopp A, Bell CM. Am J Med. 2005; 118(12):1417.
Beta-blockers for elective surgery in elderly patients: population based, retrospective cohort study
Redelmeier D, Scales D, Kopp A. BMJ. 2005; 331:932. Epub 2005 Oct 6.
Mental health-related drug utilization among older adults: prevalence, trends, and costs
Mamdani M, Rapoport M, Shulman KI, Herrmann N, Rochon PA. Am J Geriatr Psychiatry. 2005; 13(10):892-900.
Risk-treatment mismatch in the pharmacotherapy of heart failure
Lee DS, Tu JV, Juurlink DN, Alter DA, Ko DT, Austin PC, Chong A, Stukel TA, Levy D, Laupacis A. JAMA. 2005; 294(10):1240-7.
Atypical antipsychotics and parkinsonism
Rochon PA, Stukel TA, Sykora K, Gill S, Garfinkel S, Anderson GM, Normand SL, Mamdani M, Lee PE, Li P, Bronskill SE, Marras C, Gurwitz JH. Arch Intern Med. 2005; 165(16):1882-8.